An AChE inhibitor (Kis = 0.2 - 0.4 μM) that is known to prevent the breakdown of the neurotransmitter acetylcholine by binding specifically to its catalytic site; used as part of a battery of pharmacological tests to confirm a diagnoses of myasthenia gravis